Skip to main content

This is a preprint.

It has not yet been peer reviewed by a journal.

The National Library of Medicine is running a pilot to include preprints that result from research funded by NIH in PMC and PubMed.

medRxiv logoLink to medRxiv
[Preprint]. 2026 Apr 28:2026.04.03.26348150. [Version 3] doi: 10.64898/2026.04.03.26348150

Network and receptor architectures shape brain morphometry in addiction

Foivos Georgiadis, Beatrice A Milano, Sara Larivière, Kent E Hutchinson, Vince Calhoun, Chiang-Shan Ray Li, Reza Momenan, Rajita Sinha, Dick Veltman, Ruth van Holst, Anneke Goudriaan, Maartje Luijten, Martine Groefsema, Henrik Walter, Tristram Lett, Reinout Wiers, Lianne Schmaal, Julianne Flanagan, Bernice Porjesz, Jonathan Ipser, Justin Boehmer, Nicola Canessa, Ramiro Salas, Edythe London, Martin Paulus, Dan Stein, Samantha Brooks, Liesbeth Reneman, Anouk Schrantee, Francesca Filbey, Rob Hester, Murat Yücel, Valentina Lorenzetti, Nadia Solowij, Rocío Martín-Santos, Albert Batalla, Janna Cousijn, Edith Pomarol-Clotet, Eduardo A Garza-Villarreal, Marco Leyton, Elliot Stein, Cleo L Crunelle, Anne M Kaag, Antonio Verdejo-Garcia, John J Foxe, Kathleen T Brady, Aimee McRae-Clark, Alain Dagher, Amelie Haugg, Marc Walter, André Schmidt, Anne Lingford-Hughes, Louise M Paterson, Angelica M Morales, Dara G Ghahremani, Chuan Fan, Etna J E Engeli, Marcus Herdener, Boris B Quednow, Erich Seifritz, Philipp Homan, Marco De Pieri, Silke Bachmann, Daniele Zullino, Justine Y Hansen, Bratislav Misic, Sophia I Thomopoulos, Paul M Thompson, Devarshi Pancholi, Anthony Juliano, Hugh Garavan, Sofie L Valk, Boris C Bernhardt, Matthias Kirschner; the ENIGMA Addiction Working Group
PMCID: PMC13086106  PMID: 42006782

Abstract

Substance use disorders (SUD) are chronic conditions with devastating effects on brain health, functioning, and survival. In this study, we compared brain morphometry of 2,782 individuals with SUD to 1,951 controls and assessed the topographic overlap of these differences with brain connectivity and receptor architecture. Across SUD, we identified a morphometric signature involving frontal, parietal, temporal and limbic systems that overlapped with cortical hub regions and harbored cortical and subcortical disease epicenters. Findings were highly consistent across six substances and numerous robustness and generalizability analyses. Transdiagnostic comparisons showed high spatial overlap of SUD epicenters with those of schizophrenia and bipolar disorder, suggesting shared network-constrained cortical differences. Finally, multivariate mapping revealed that SUD brain differences aligned with two neurotransmitter axes contrasting cannabinoid-opioid and dopaminergic systems. These findings indicate that addiction-related brain differences are shaped by connectome and neurotransmitter architecture, positioning brain network and neurochemical organization as key principles of SUD-related brain alterations.

Full Text Availability

The license terms selected by the author(s) for this preprint version do not permit archiving in PMC. The full text is available from the preprint server.


Articles from medRxiv are provided here courtesy of Cold Spring Harbor Laboratory Preprints

RESOURCES